Publicaciones (23) Publicaciones en las que ha participado algún/a investigador/a

2001

  1. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: Phase I study

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 6, pp. 1876-1878

  2. Análisis de los orígenes de la Ley del Deporte de Andalucía y su aplicación reglamentaria

    Revista jurídica de deporte y entretenimiento: deportes, juegos de azar, entretenimiento y música, Núm. 6, pp. 45-54

  3. Biomechanical análisis of the world championships in athletics sevilla ’99: 100, 200, 400 m sprint events

    New Studies in Athletics, Vol. 16, pp. 25-60

  4. Caffeine ingestion attenuates the Vo2 slow component during intense exercise

    Japanese Journal of Physiology, Vol. 51, Núm. 6, pp. 761-764

  5. Crisis del Estado de Bienestar y Derechos Humanos

    Asamblea: revista parlamentaria de la Asamblea de Madrid, Núm. 5, pp. 131-144

  6. Differences between two new quinolones (gemifloxacin and trovafloxacin) and ciprofloxacin in their concentration-dependent killing of Streptococcus pneumoniae

    Chemotherapy, Vol. 47, Núm. 6, pp. 409-414

  7. Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3

    British Journal of Sports Medicine, Vol. 35, Núm. 5, pp. 303-307

  8. Effects of endurance training on the breathing pattern of professional cyclists

    Japanese Journal of Physiology, Vol. 51, Núm. 2, pp. 133-141

  9. Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 2, pp. 608-611

  10. El deporte y la Constitución

    Boletín jurídico de la Universidad Europea de Madrid, Núm. 4

  11. Hormone levels of world class cyclists during the tour of Spain stage race

    British Journal of Sports Medicine, Vol. 35, Núm. 6, pp. 424-430

  12. Immunolabelling, histochemistry and in situ hybridisation in human skeletal muscle fibres to detect myosin heavy chain expression at the protein and mRNA level

    Journal of Anatomy, Vol. 199, Núm. 3, pp. 329-337

  13. In vitro susceptibility of Neisseria meningitidis isolates to gemifloxacin and ten other antimicrobial agents

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 20, Núm. 2, pp. 150-151

  14. Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers

    International Journal of Antimicrobial Agents, Vol. 18, Núm. 3, pp. 231-238

  15. Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones

    Journal of Antimicrobial Chemotherapy, Vol. 48, Núm. 6, pp. 907-909

  16. Physiology of professional road cycling

    Sports Medicine, Vol. 31, Núm. 5, pp. 325-337

  17. Plasma oxytocin during intense exercise in professional cyclists

    Hormone Research, Vol. 55, Núm. 3, pp. 155-159

  18. Prediction of In-vivo efficacy by In-vitro early bactericidal activity with oral β-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin

    Journal of Chemotherapy, Vol. 13, Núm. 2, pp. 118-125

  19. Preferred pedalling cadence in professional cycling

    Medicine and Science in Sports and Exercise, Vol. 33, Núm. 8, pp. 1361-1366

  20. Seroprevalencia de hepatitis virales en pacientes programados para artroplastia de sustitución de cadera y rodilla

    Revista española de cirugía osteoarticular, Vol. 36, Núm. 207, pp. 128-133